BAKSH DOLORES has a total of 11 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are RXI PHARMACEUTICALS CORP, MCSWIGGEN JAMES and BLASTICON BIOTECH FORSCHUNG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Baksh Dolores | 11 |
#2 | Davies John E | 10 |
#3 | Zandstra Peter | 6 |
#4 | Sarugaser Rahul | 3 |
#5 | Hosseini Morris | 3 |
#6 | Lickorish Anthony David Sutton | 2 |
#7 | Ennis Jane | 1 |
#8 | Wang Xianyan | 1 |
#9 | Cao Lan | 1 |
#10 | Wong Matthew Q | 1 |
Publication | Filing date | Title |
---|---|---|
AU2012227326A1 | Progenitor cells from wharton's jelly of human umbilical cord | |
CA2843001A1 | Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |